The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level
Tarih
2014Yazar
Aliyev, Anar
Vatankulu, Betül
Halac, Metin
OZHAN, Meftune
Sonmezoglu, Kerim
Asa, Sertac
Uslu, Lebriz
AKSOY, Sabire Yilmaz
Sager, Sait
Üst veri
Tüm öğe kaydını gösterÖzet
In the follow-up of differentiated thyroid cancer (DTC) after a successful total-near total thyroidectomy and I-131 ablation therapy, anti-thyroglobulin antibodies (anti-Tg) may be persistently or progressively increased in the patients with an undetectable serum thyroglobulin (Tg) level. In these cases, further investigation was performed to search for recurrence/metastases. The aim of our study was clarifying the role of FDG-PET/CT in detecting recurrence/metastasis in patients with DTC with negative serum Tg and elevated anti-Tg level.
Koleksiyonlar
- Makale [92796]